Mineralys Therapeutics Inc
MLYS12.980USD
-0.685-5.01%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
842.09MMarket Cap
LossP/E TTM
Mineralys Therapeutics Inc
12.980
-0.685-5.01%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Total equity
Cash, cash equivalents and short-term investments
1.32%343.03M
-16.22%198.19M
3.88%263.60M
19.16%311.12M
25.10%338.56M
114.85%236.57M
109.80%253.76M
--261.10M
--270.64M
--110.11M
--120.95M
- Cash and cash equivalents
82.49%165.01M
131.40%114.09M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-43.78%49.30M
76.28%86.30M
--101.14M
--138.25M
--87.70M
--48.95M
-Short-term investments
-28.26%178.02M
-55.09%84.10M
-0.68%166.33M
52.08%243.26M
87.43%248.15M
735.66%187.26M
132.59%167.46M
--159.96M
--132.39M
--22.41M
--72.00M
Prepaid expenses
39.08%11.48M
-42.85%7.16M
-64.45%4.13M
-17.94%6.89M
78.08%8.25M
364.12%12.54M
1144.80%11.61M
--8.39M
--4.63M
--2.70M
--933.00K
Total current assets
2.22%354.51M
-17.56%205.35M
0.89%267.73M
18.00%318.00M
25.99%346.82M
120.81%249.10M
117.72%265.38M
--269.49M
--275.27M
--112.81M
--121.89M
Non-current assets
Net Fixed Assets
-25.49%38.00K
--53.00K
--69.00K
--42.00K
--51.00K
----
----
----
----
----
----
Other non-current assets
4.75%397.00K
878.43%499.00K
786.27%452.00K
780.39%449.00K
871.79%379.00K
--51.00K
-90.96%51.00K
--51.00K
--39.00K
----
--564.00K
Total non-current assets
1.16%435.00K
-78.21%552.00K
-95.72%521.00K
-97.74%491.00K
-98.62%430.00K
55.30%2.53M
2059.57%12.18M
--21.73M
--31.16M
--1.63M
--564.00K
Total assets
2.22%354.94M
-18.17%205.90M
-3.35%268.25M
9.37%318.49M
13.32%347.25M
119.88%251.64M
126.67%277.56M
--291.22M
--306.44M
--114.44M
--122.45M
Liabilities
Current liabilities
-Other payables
----
----
--0.00
----
----
--0.00
----
--0.00
--4.00M
----
----
Accrued expenses
-12.92%13.01M
43.38%14.17M
254.02%28.21M
565.42%26.69M
258.09%14.94M
60.41%9.88M
71.14%7.97M
--4.01M
--4.17M
--6.16M
--4.66M
Short-term debt and lease liabilities
----
----
--0.00
----
----
--0.00
----
--0.00
--0.00
--0.00
----
-Short-term debt
----
----
----
----
----
----
----
----
----
--0.00
----
Other current liabilities
----
----
--0.00
----
----
--0.00
----
--0.00
--4.00M
----
----
Total current liabilities
-30.30%13.39M
39.73%14.65M
131.27%31.32M
357.50%28.40M
81.86%19.20M
29.94%10.48M
87.58%13.54M
--6.21M
--10.56M
--8.07M
--7.22M
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-Long-term debt
----
----
--0.00
----
----
--0.00
----
--0.00
--0.00
----
----
Other non-current liabilities
----
----
--0.00
----
----
--0.00
----
--0.00
--0.00
----
----
Total non-current liabilities
----
----
--0.00
----
----
--0.00
----
--0.00
--0.00
----
----
Total liabilities
-30.30%13.39M
39.73%14.65M
131.27%31.32M
357.50%28.40M
81.86%19.20M
29.94%10.48M
87.58%13.54M
--6.21M
--10.56M
--8.07M
--7.22M
Shareholders' equity
Common equity
41.72%686.28M
34.96%493.77M
34.63%490.50M
34.41%487.32M
34.04%484.26M
67526.99%365.86M
112695.98%364.33M
--362.57M
--361.29M
--541.00K
--323.00K
Preferred equity
----
----
----
----
----
----
----
----
----
----
--158.64M
Retained earnings
-120.67%-344.73M
-142.58%-302.52M
-152.77%-253.57M
-154.30%-197.23M
-138.80%-156.22M
-136.14%-124.71M
-129.37%-100.32M
---77.56M
---65.42M
---52.81M
---43.74M
Capital reserves
41.72%686.28M
34.96%493.77M
34.63%490.50M
34.41%487.32M
34.04%484.26M
67651.48%365.86M
113045.03%364.33M
--362.56M
--361.29M
--540.00K
--322.00K
Total equity
4.12%341.56M
-20.69%191.26M
-10.26%236.93M
1.78%290.10M
10.87%328.05M
126.70%241.15M
129.12%264.01M
--285.01M
--295.88M
--106.38M
--115.23M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
